• Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • Goverment Affairs
  • 2024 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources

To Buy Cozaar Online Visit Our Pharmacy ↓

Click HERE To Buy Cozaar Online ↓




  • **cozaar and Pregnancy: What You Should Know**

    Understanding Cozaar: the Basics You Need to Know


    Cozaar, known generically as losartan, is an angiotensin receptor blocker (ARB) primarily used to manage high blood pressure. By blocking the action of a natural chemical in your body, it allows blood vessels to relax and widen, thereby reducing blood pressure levels. Understanding how Cozaar works is essential for anyone, especially pregnant women who may have unique considerations.

    This medication is typically prescribed for hypertension and can also be beneficial in protecting kidney function for individuals with diabetes. Cozaar promotes better heart health by reducing the strain on the cardiovascular system. Awareness of these aspects ensures patients have a clear picture of its intended use and benefits.

    For pregnant women, hormonal changes can significantly affect blood pressure. Maintaining these levels is crucial as high blood pressure can lead to complications for both the mother and child. Knowing the implications of taking Cozaar during this sensitive period can empower women to make informed choices regarding their health.

    Lastly, it’s essential to recognize that not everyone may respond to Cozaar in the same way. Factors such as age, weight, and medical history play a role in how one’s body processes this medication. As you navigate the complexities of managing hypertension, understanding the fundamentals of Cozaar lays the groundwork for making educated decisions in a healthcare setting.

    Feature Cozaar (Losartan)
    Drug Class Angiotensin Receptor Blocker (ARB)
    Primary Use Management of High Blood Pressure
    Additional Benefits Kidney protection in diabetic patients
    Considerations Not always suitable for pregnant women



    Cozaar's Effects on Blood Pressure during Pregnancy



    During pregnancy, maintaining stable blood pressure is crucial for both the expectant mother and her baby. Cozaar, a medication commonly used to treat high blood pressure, works by relaxing blood vessels, leading to a reduction in blood pressure levels. However, its effects can vary during this sensitive time, as hormonal changes and increased blood volume can alter how the body responds to medications.

    Studies indicate that controlling hypertension is vital to prevent complications such as preeclampsia. While some women may find that cozaar helps manage their blood pressure effectively, others might experience different outcomes, necessitating careful monitoring throughout pregnancy.

    Therefore, understanding the implications of taking cozaar during this period is essential. Individual responses can differ significantly, making it imperative for pregnant women to closely observe their health and discuss any concerns with their healthcare provider, ensuring any necessary adjustments to medication are made promptly.



    Potential Risks of Cozaar Use in Pregnant Women


    Cozaar, a medication commonly used to treat hypertension, poses significant concerns when taken by pregnant women. Evidence suggests that its usage during pregnancy may lead to serious complications for both the mother and the developing fetus. These risks include potential disruptions in fetal kidney development, which can result in reduced amniotic fluid levels—a condition known as oligohydramnios.

    Moreover, there is a heightened risk of neonatal complications, including lung issues and other long-term health challenges. These adverse effects stem from Cozaar’s classification as an angiotensin receptor blocker, which may interfere with critical vascular and kidney development during crucial trimesters.

    As the stakes are high, it’s essential for expectant mothers to approach their treatment plans with caution. Consulting healthcare practitioners about the risks associated with Cozaar can guide safer alternatives that prioritize both maternal and fetal health.

    In sum, being informed about the implications of using Cozaar is vital for anyone navigating pregnancy. Awareness can help ensure a healthier journey for both mother and child, emphasizing the importance of tailored medical advice.



    Alternatives to Cozaar for Managing Hypertension



    When looking for alternatives, several safe options are available for managing hypertension during pregnancy. Medications such as methyldopa and labetalol have been widely studied and are often preferred due to their proven safety records. Methyldopa works effectively by stimulating the central nervous system to relax blood vessels, while labetalol combines both alpha and beta-blocker properties, providing substantial control over blood pressure.

    Lifestyle changes can also play a critical role in managing hypertension. Incorporating a balanced diet rich in fruits, vegetables, and whole grains can make a significant difference. Regular physical activity, tailored to each individual's comfort, promotes overall well-being and can help manage blood pressure more effectively during pregnancy.



    Importance of Consulting a Healthcare Provider


    During pregnancy, managing hypertension is critical for both maternal and fetal health, and navigating the complexities of medication like Cozaar requires expert guidance. Expectant mothers are often bombarded with advice, but the most reliable source remains a healthcare provider. By engaging in open conversations about personal medical history and any concerns regarding Cozaar, patients can make informed decisions that prioritize their wellbeing and that of their baby.

    Healthcare professionals can provide tailored recommendations that consider the unique challenges of pregnancy. They can weigh the benefits and risks of continuing Cozaar against potential alternatives, ensuring that any hypertension treatment is safe. Furthermore, they can monitor blood pressure levels closely and make adjustments as needed during this transformative time.

    Understanding the nuances of medication safety is paramount for pregnant women. Consultation with a healthcare provider not only offers peace of mind but also ensures that the treatment plan aligns with best practices, safeguarding both mother and child. Seeking advice is a proactive step towards a healthy pregnancy.

    Medication Category During Pregnancy Considerations
    Cozaar Category D Potential risks; needs careful evaluation
    Alternatives Vary by individual Must be discussed with healthcare provider



    Navigating Pregnancy: Essential Tips for Medication Safety


    During pregnancy, the safety of medications should be a paramount concern for expectant mothers. It's crucial to thoroughly research any medication, as numerous substances can affect both the mother and developing fetus. Women should maintain open communication with healthcare providers about all medications they are taking, whether prescribed, over-the-counter, or herbal. This dialogue ensures that any potential risks are identified, and alternatives can be discussed if necessary.

    Creating a medication checklist can also serve as a helpful tool. This list should include dosages, purposes, and frequencies for each medication, enabling clear discussions with medical professionals. Moreover, staying informed about potential side effects and being aware of any changes in health during pregnancy will empower women to make safe choices regarding their medication use and overall well-being.





ARIZONA PSYCHIATRIC SOCIETY 2024-2025 EXECUTIVE Board

President: Nicholas Ahrendt, MD President-Elect: Margaret Balfour, MD, PhDVice President: Brenner Freeman, MDTreasurer: Robert Rymowicz, DOSecretary: Chiranjir "Ravi" Narine, MD Co Resident-Fellow Member Representatives: Nehal Samra, MD Creighton Matthew Mitchell, MD UA-PhoenixGagan Singh, MD UA-Tucson
APA Assembly Representatives: Jason Curry, DO (serves term concluding 2024) Jasleen Chhatwal, MBBS, MD (two-year term concluding 2024)Payam Sadr, MD (one-year term concluding 2024) Past President Gagandeep Singh, MD, DFAPA Stephen "Larry" Mecham, DO The Society thanks these members for their leadership.

Celebrating our members

Chase was born and raised in Phoenix, AZ, and attended ASU for a bachelor’s degree in business then attended KCUMB for medical school in Kansas City. He was excited to return home to AZ when he found out he'd been matched with UACOM – Phoenix for his psychiatry residency.
He was first drawn to the field of psychiatry during his years in medical school as he found the psychiatric subject matter and the patients to be the most engaging and interesting of all his studies. He quickly came to realize that without a healthy mind, one is unable to thoroughly experience life constructive way. He wanted to be the person to help those struggling with mental illness as he found these cases and experiences to be the most rewarding in medicine.
Dr. Crookham said he has been lucky enough to have been matched at a great psychiatric residency program where he gets to learn from great mentors and colleagues every day. He believes his passion for psychiatry along with the relationships he's developed with his colleagues and mentors will carry him to be a lifelong learner and devoted psychiatrist for his future patients.
Meghan is a graduate of Lincoln Memorial University, DeBusk College of Osteopathic Medicine.
She received her Bachelor of Arts from the University of Denver in French and Biology with a concentration in Cognitive Neuroscience.
She is currently a chief resident at UACOM-Tucson in her final year of psychiatry training and will be starting a fellowship in Addiction Medicine at the University of Arizona, Tucson in July.
Her professional interests include physician mental health, adult consult liaison and addiction psychiatry.
In her personal time, she enjoys home design projects, spending time with family, learning about plants, and exploring new places.
Dr. Hintze is currently honeymooning in Japan! Congratulations!!
Danny is originally from Phoenix. Graduated from Brophy, ASU, and UA Tucson Medical School. His background is in economics, philosophy of science, and rational decision-making.
He was drawn to psychiatry because of the conceptual complexity and the profound impact even relatively simple pharmaceutical, medical, and psychotherapeutic interventions can have to empower patients and their families.
As a mentor, he wanted to recognize the many people within the Arizona Medical Community, particularly at UA Tucson, Valleywise, and within organized medicine who have worked to protect and promote medicine as a joyful, compassionate, and healing experience for patients and for all of us who help care for them.

ARIZONA PSYCHIATRIC SOCIETY past presidents

Otto L. Bendheim, M.D. 1960-1961Warren S. Williams, M.D. 1961-1963T. Richard Gregory, M.D. 1963-1964Boris Zemsky, M.D. 1964-1965 Hal J. Breen, M.D. 1965-1966Joseph M. Green, M.D. 1966-1967Irene M. Josselyn, M.D. 1967-1968Hubert R. Estes, M.D. 1968-1969Richard H. Bruner, M.D. 1969-1970Thomas F. Kruchek, M.D. 1970-1971David S. Burgoyne Sr., M.D. 1971-1972Marshall W. Jones, M.D. 1972-1973Harold D. Haeussler, M.D. 1973-1974William B. Haeussler, M.D. 1974-1975Edward S. Gelardin, M.D. 1975-1976Hugo L. Cozzi, M.D. 1976-1977Robert F. Meyer, M.D. 1977-1978James E. Campbell, M.D. 1978-1979Stuart M. Gould, M.D. 1979-1980Elliot M. Heiman, M.D. 1980-1981Stephen V. Shanfield, M.D. 1981-1982Jerry A. Biggs, M.D. 1982-1983Robert C. Shapiro, M.D. 1983-1984Dennis C. Westin, M.D. 1984-1985John H. Jarvis, M.D. 1985-1986James G. Hill, M.D. 1986-1987Robert P. Bevan, M.D. 1987-1988Eugene J. Kinder, M.D. 1988-1989 James M. Campbell, M.D. 1989-1990David S. Burgoyne II, M.D. 1990-1991
Stuart W. Hollingsworth, M.D. 1991-1992Kevin J. Leehey, M.D. 1992-1993Stephen S. Brockway, M.D. 1993-1994Michael H. Stumpf, M.D. 1994-1995Lauro Amezcua-Patino, M.D. 1995-1996David S. Burgoyne II, M.D. 1997-1998Glenn Lippman, M.D. 1998-1999Lisa Jones, M.D. 1999-2000David J. Coons, M.D. 2000-2001James M. Campbell, M.D. 2001-2002Bradley Johnson, M.D. 2002-2003David W. Leicken, M.D. 2003-2004Thomas N. Crumbley, M.D. 2004-2006Jeffrey L. Schwimmer, M.D., M.P.H. 2006-2007Stephen O. Morris, M.D. 2007-2008Jack L. Potts, M.D. 2008-2009Elizabeth A. Kohlhepp, M.D. 2009-2010Michael E. Brennan, M.D. 2010-2011Gretchen Alexander, M.D. 2011-2012Tariq M. Ghafoor, M.D. 2012-2013Joanna K. Kowalik, M.D., M.P.H., 2013-2014Payam M. Sadr, M.D., 2014-2015Roland Segal, M.D., 2015-2016Gurjot Marwah, M.D., 2016-2017Aaron Wilson, M.D., 2017-2018Mona Amini, M.D., 2018-2019 Don J. Fowls, M.D., 2019-2020 Jasleen Chhatwal, M.B.B.S., M.D., 2020-2022 Stephen Larry Mecham, DO, 2022-2023 Gagandeep Singh, MD, DFAPA 2023-2024
Main Menu
  • Home
  • About APS
  • APS News
  • Job Postings and Ads
  • Events and Education
  • 2023 Annual Meeting
  • Education-OUD
  • Education-On Demand
  • Mental Health Resources
Contact Information
Address: 2401 West Peoria Avenue, Suite 315 Phoenix, Arizona 85029
Phone: 602-909-4388
E-mail: admin@azpsych.org
Social
The Arizona Psychiatric Society is committed to ensuring the accessibility of its website to people with disabilities. If you have trouble accessing any of the Arizona Psychiatric Society's resources, please contact us at admin@azpsych.org for assistance Copyright © 2020 Network Solutions, LLC, A Web.com Company. All rights reserved.

We use cookies to enable essential functionality on our website, and analyze website traffic. By clicking Accept you consent to our use of cookies. Read about how we use cookies.

Your Cookie Settings

We use cookies to enable essential functionality on our website, and analyze website traffic. Read about how we use cookies.

Cookie Categories
Essential

These cookies are strictly necessary to provide you with services available through our websites. You cannot refuse these cookies without impacting how our websites function. You can block or delete them by changing your browser settings, as described under the heading "Managing cookies" in the Privacy and Cookies Policy.

Analytics

These cookies collect information that is used in aggregate form to help us understand how our websites are being used or how effective our marketing campaigns are.